NCT03041298View on ClinicalTrials.gov

Post Marketing Surveillance Study for Evaluation of Efficacy and Safety of Dotarem in Magnetic Resonance Mammography

CompletedOBSERVATIONAL
Enrollment

1,537

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

October 31, 2013

Study Completion Date

December 31, 2013

Conditions
MR Mammography With Dotarem
Interventions
PROCEDURE

MR mammography with Dotarem

Sponsors

Lead Sponsor

Guerbet
All Listed Sponsors
lead

Guerbet

INDUSTRY

NCT03041298 - Post Marketing Surveillance Study for Evaluation of Efficacy and Safety of Dotarem in Magnetic Resonance Mammography | Biotech Hunter | Biotech Hunter